RecruitingPhase 3NCT07513376
A Clinical Trial of Adjuvant Intismeran (V940) With or Without Pembrolizumab Coformulated With Berahyaluronidase Alfa (MK-3475A) in High-Risk Stage I Non-Small Cell Lung Cancer (V940-014)
Sponsor: Merck Sharp & Dohme LLC
Albany, NY · Syracuse, NY · White Plains, NY · +21 more sites